CLASS II Device recall · Reported 15 Jan 2014 · FDA Enforcement Report

Jelco Smiths Medical Hypodermic Needle-Pro¿ Fixed Needle recalled

Smiths Medical ASD is recalling Jelco Smiths Medical Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringe, distributed nationwide in the US. The recall was initiated on 10 Jul 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 2358702
Quantity recalled54000

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0646-2014
FDA event ID
67034
Recalling firm
Smiths Medical ASD, Keene, NH
Classification
Class II
Status
Terminated
Recall initiated
10 Jul 2013
FDA classified
8 Jan 2014
Reported
15 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

10 Jul 2013Recall initiated by company
8 Jan 2014Classified by FDA+182 days
15 Jan 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Visible orange/ brown particulate on the needles of the 29g Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringes

Product as listed by the FDA

Jelco Smiths Medical Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringe, 0.5ml 29g x 1/2 in. Distributed by: Cardinal Health, Dublin, OH (Co-Brand) Reference: ED052905IN Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringes are sterile, latex free, non-pyrogenic, single use devices intended for injection of U-100 insulin only. The syringe has an integral rotational needle protection sheath.

Where it was distributed

Worldwide Distribution: US (nationwide) including states of: AZ, CA, FL, IL, LA, MO, MS, NH, NY, OH, PA, TN, TX, VA, WI, and WV; and countries of: Canada, Italy and Spain.

Nationwide ArizonaCaliforniaFloridaIllinoisLouisianaMissouriMississippiNew HampshireNew YorkOhioPennsylvaniaTennesseeTexasVirginiaWisconsinWest Virginia

Questions about this recall

Is Jelco Smiths Medical Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringe recalled?

Yes. Smiths Medical ASD recalled Jelco Smiths Medical Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringe on 10 Jul 2013. The recall is Class II and its status is Terminated. Recall number Z-0646-2014.

Why was it recalled?

Visible orange/ brown particulate on the needles of the 29g Hypodermic Needle-Pro¿ Fixed Needle Insulin Syringes

Which lots are affected?

Lot Numbers: 2358702

Where was it sold?

Worldwide Distribution: US (nationwide) including states of: AZ, CA, FL, IL, LA, MO, MS, NH, NY, OH, PA, TN, TX, VA, WI, and WV; and countries of: Canada, Italy and Spain.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Smiths Medical ASD

All 284

Other Syringes & Needles recalls

All 1,060